Sullivan A - Search Results

1

Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipients.

Imami N, Hardy G, Pires A, Burton C, Sullivan A, Gotch F. Imami N, et al. Among authors: sullivan a. HIV Med. 2001 Jul;2(3):146-53. doi: 10.1046/j.1468-1293.2001.00068.x. HIV Med. 2001. PMID: 11737394 Free article. Review.

2

A retrospective study of neutropenia in HIV disease.

Moore DA, Sullivan A, Hilstead P, Gazzard BG. Moore DA, et al. Among authors: sullivan a. Int J STD AIDS. 2000 Jan;11(1):8-14. doi: 10.1258/0956462001914832. Int J STD AIDS. 2000. PMID: 10667894

3

Efficacy of a nelfinavir- and nevirapine-containing salvage regimen.

Sullivan AK, Nelson MR, Shaw A, Moyle GJ, Mandalia S, Gazzard BG, Asboe D. Sullivan AK, et al. HIV Clin Trials. 2000 Jul-Aug;1(1):7-12. doi: 10.1310/64pf-wk1q-96y5-axjq. HIV Clin Trials. 2000. PMID: 11590484 Clinical Trial.

4

Immunomodulation in HIV-1 infection in the HAART era.

Imami N, Sullivan AK, Gotch FM. Imami N, et al. Among authors: sullivan ak. J HIV Ther. 2001 Nov;6(4):77-84. J HIV Ther. 2001. PMID: 11740408 Review. No abstract available.

5

Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection.

Burton CT, Hardy GA, Sullivan AK, Nelson MR, Gazzard B, Gotch FM, Imami N. Burton CT, et al. Among authors: sullivan ak. Clin Exp Immunol. 2002 Nov;130(2):286-92. doi: 10.1046/j.1365-2249.2002.01993.x. Clin Exp Immunol. 2002. PMID: 12390317 Free PMC article. Clinical Trial.

6

Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy.

Sullivan AK, Hardy GA, Nelson MR, Gotch F, Gazzard BG, Imami N. Sullivan AK, et al. AIDS. 2003 Mar 7;17(4):628-9. doi: 10.1097/00002030-200303070-00020. AIDS. 2003. PMID: 12598786

7

Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune).

Pido-Lopez J, Burton C, Hardy G, Pires A, Sullivan A, Gazzard B, Aspinall R, Gotch F, Imami N. Pido-Lopez J, et al. Among authors: sullivan a. AIDS Res Hum Retroviruses. 2003 Feb;19(2):103-9. doi: 10.1089/088922203762688603. AIDS Res Hum Retroviruses. 2003. PMID: 12639245

8

Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Sullivan AK, Burton CT, Nelson MR, Moyle G, Mandalia S, Gotch FM, Gazzard BG, Imami N. Sullivan AK, et al. Scand J Immunol. 2003 Jun;57(6):600-7. doi: 10.1046/j.1365-3083.2003.01276.x. Scand J Immunol. 2003. PMID: 12791099 Free article.

9

Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness.

Hardy GA, Imami N, Sullivan AK, Pires A, Burton CT, Nelson MR, Gazzard BG, Gotch FM. Hardy GA, et al. Among authors: sullivan ak. Clin Exp Immunol. 2003 Oct;134(1):98-106. doi: 10.1046/j.1365-2249.2003.02256.x. Clin Exp Immunol. 2003. PMID: 12974761 Free PMC article.

10

Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses.

Hardy GA, Imami N, Sullivan AK, Nelson MR, Gazzard B, Gotch FM. Hardy GA, et al. Among authors: sullivan ak. AIDS. 2004 Nov 5;18(16):2199-202. doi: 10.1097/00002030-200411050-00014. AIDS. 2004. PMID: 15577655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,744 results

Search Page

Filters